Skip to main content
. 2016 Oct 3;11(10):e0163767. doi: 10.1371/journal.pone.0163767

Table 2. Levels of different serum lipid components and incidences of different types of dyslipidemia in different CKD stages.

HDL—C indicates high-density lipoprotein cholesterol; LDL-C low-density lipoprotein cholesterol; TC total cholesterol.

CKD stages 1 2 3 4/5 P for trend
HDL-C(mg/dL) 53.58±31.92 45.98±22.04 42.18±21.66 39.52±14.44 <0.001
LDL-C(mg/dL) 109.44±46.74 113.24±55.48 108.68±45.60 105.26±42.56 0.123
TC(mg/dL) 188.86±50.92 188.86±63.46 185.82±65.36 178.60±60.04 0.013
Triglyceride(mg/dL) 184.80±197.12 176.88±154.88 188.32±180.40 167.20±124.08 0.254
Hypo HDL cholesteremia (na, %) 156 (35.8) 283 (44.5) 320 (52.9) 194 (54.0) <0.001
Hyper LDL cholesteremia (n, %) 140 (32.1) 195 (30.7) 164 (27.1) 86 (24.0) 0.004
Hypercholesteremia (n, %) 170 (39.0) 236 (37.1) 217 (35.9) 104 (29.0) 0.005
Hypertriglyceridemia (n, %) 197 (45.2) 287 (45.1) 278 (46.0) 166 (46.2) 0.702
Dyslipidemia (n, %) 327 (75.0) 504 (79.2) 490 (81.0) 283 (78.8) 0.106

a The number of the population.